<DOC>
	<DOCNO>NCT02935582</DOCNO>
	<brief_summary>Multinational real-life study current psoriasis treatment strategy , topical treatment pattern treatment outcomes treatment , include newly introduce calcipotriol/betamethasone dipropionate aerosol foam fix combination product Enstilar® ( calcipotriol/betamethasone dipropionate ) .</brief_summary>
	<brief_title>PSOREAL - Managing PSOriasis REAL World</brief_title>
	<detailed_description>This multinational study aim describe current treatment pattern outcomes diversity real life setting : local difference access drug current treatment practice , regional cultural difference , cover adult patient background , sex , socio-economic standing , health background , comorbidity co-medication . A total around 1200 real-life prescribers 15-20 country around globe expect participate year , country contribute data study around 2 year , start data collection within first year local market introduction Enstilar® . The real-life prescribing utilization pattern topical prescription product approve treatment psoriasis vulgaris individual participate country map performance product real life investigate base primarily baseline data investigator patient report data contribute individual patient 1 year . Patients expect enter data electronic device baseline time treatment change key event , investigator expect contribute data contact patient . Patients approach informed consent participate study individual treatment plan decide . The study aim include two patient topical treatment every patient plan receive Enstilar® order ensure sufficient sample Enstilar® treat patient capture diversity real-life prescription pattern patient Enstilar® , allow sufficiently power comparison Enstilar® real-world treatment strategy . A systematic approach use select eligible patient approach study participation order minimize selection bias control seasonal variation .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Betamethasone benzoate</mesh_term>
	<mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
	<mesh_term>Betamethasone</mesh_term>
	<mesh_term>Betamethasone Valerate</mesh_term>
	<mesh_term>Betamethasone sodium phosphate</mesh_term>
	<mesh_term>Calcipotriene</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<criteria>Adult age Psoriasis vulgaris Plaques body ( trunk and/or extremity ) least mild severity time inclusion Decision prescribe topical psoriasis treatment body use prescription NOT routine renewal prescription ongoing therapy Signed date informed consent Willingness ability enter personal disease treatment information onto secure webpage one year individual study period , use exist access PC electronic device personal access code . Participation active treatment phase clinical trial Previous enrollment study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Topical</keyword>
	<keyword>Real-world</keyword>
	<keyword>Local standard care</keyword>
	<keyword>Non-interventional</keyword>
	<keyword>Calcipotriol</keyword>
</DOC>